INOVIO PHARMACEUTICALS, INC. Noncontrolling Interest, Increase from Subsidiary Equity Issuance
INOVIO PHARMACEUTICALS, INC. (INO) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $2.38 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-01.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2023-03-01
- INOVIO PHARMACEUTICALS, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2020-09-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2020-06-30 was $209.97K.
- INOVIO PHARMACEUTICALS, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2020-03-31 was $2.17M, a 28.39% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2019-03-31 was $3.03M.
- INOVIO PHARMACEUTICALS, INC. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2020 was $2.38M, a 19.60% decline from fiscal 2019.
- INOVIO PHARMACEUTICALS, INC. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2019 was $2.96M.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 3 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 6 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 9 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|---|---|---|
| 2020-12-31 | $2.38M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $209.97K derived: sum of 2 quarters · filed 2021-11-09 | $2.38M derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $209.97K 10-Q · filed 2021-11-09 | $2.38M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-03-31 | $2.17M 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $2.96M 10-K · filed 2022-03-01 | |||
| 2019-03-31 | $3.03M 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |